Cellosaurus logo
expasy logo

Cellosaurus 22Rv1-CabR1 (CVCL_A6PG)

[Text version]
Cell line name 22Rv1-CabR1
Accession CVCL_A6PG
Resource Identification Initiative To cite this cell line use: 22Rv1-CabR1 (RRID:CVCL_A6PG)
Comments Population: Caucasian.
Characteristics: Established from xenografts that were obtain by subcutaneously injecting 22Rv1 cells into the flanks of 8 weeks old, athymic male BALB/c nude mice and treating them with cabazitaxel (PubMed=31799745).
Selected for resistance to: ChEBI; CHEBI:63584; Cabazitaxel.
Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
Sequence variations
  • Mutation; HGNC; 7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; 7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; 8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; 11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
Disease Prostate carcinoma (NCIt: C4863)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1045 (22Rv1)
Sex of cell Male
Age at sampling Adult
Category Cancer cell line
Publications

PubMed=31799745; DOI=10.1002/pros.23935
Ylitalo E.B., Thysell E., Thellenberg-Karlsson C., Lundholm M., Widmark A., Bergh A., Josefsson A., Brattsand M., Wikstrom P.
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.
Prostate 80:214-224(2020)

Cross-references
Cell line databases/resources cancercelllines; CVCL_A6PG
Encyclopedic resources Wikidata; Q107113178
Entry history
Entry creation20-May-2021
Last entry update05-Oct-2023
Version number5